SIRS-Lab successfully raises EURO 10M new equity capital to introduce its first sepsis diagnostic tests to the market
Jena/Geneva/Erfurt, December 14th 2006 – SIRS-Lab, the innovation leader in molecular diagnostics for life threatening infections announced today that it…